Kikuchi-Fujimoto disease (KFD) is a rare, benign, and self-limited disease that presents with cervical lymphadenopathy and systemic symptoms. Histologic evaluation is often necessary to differentiate KFD from other entities.
Methods
Electronic medical records and diagnostic material were reviewed for 14 children diagnosed with KFD and 6 children diagnosed with infectious mononucleosis (IM) from 2013-2021. Four cases of KFD were further characterized using targeted DNA-based next-generation sequencing.
Results
Systemic symptoms were present in 86% (n = 12/14) of KFD patients, the most common being fever. Laboratory values worrisome for malignancy included cytopenia(s) (n = 9/12), elevated ESR and/or CRP (n = 9/12), elevated ferritin (n = 7/7), and elevated LDH (n = 7/10). Histologically, lymph nodes showed characteristic necrotic foci without neutrophils surrounded by MPO+ “crescentic” histiocytes. Immunoblasts and CD123+ plasmacytoid dendritic cells (pDCs) were also increased surrounding the necrosis. IM lymph nodes showed similar features when necrosis was present but increases in pDCs were patchy and rare neutrophils were seen in the necrotic foci. Molecular analysis of 4 KFD cases did not identify pathogenic variants.
Conclusion
While the signs/symptoms of KFD are worrisome, there are pathologic features that help differentiate it from potential mimics. We did not identify characteristic molecular features to aid in the work-up of these cases.
KikuchiM. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytosis. Nippon Ketsueki Gakkai Zasshi. 1972;35:379-380.
2.
FujimotoYKozimaYYamaguchiK. Cervical subacute necrotizing lymphadenitis: a new clinicopathologic entity. Naika. 1972;20:920-927.
3.
DorfmanRF. Histiocytic necrotizing lymphadenitis of Kikuchi and Fujimoto. Arch Pathol Lab Med. 1987;111:1026-1029.
4.
KucukardaliYSolmazgulEKunterE, et al. Kikuchi-Fujimoto disease: analysis of 244 cases. Clin Rheumatol. 2007;26:50-54.
5.
KuoTT. Kikuchi’s disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy. Am J Surg Pathol. 1995;19:798-809.
6.
DumasGPrendkiVHarocheJ, et al. Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature. Medicine (Baltim). 2014;93:372-382.
7.
ChenLCWangCJChangYC, et al. Distribution of lymphadenopathy in patients with Kikuchi disease. J Microbiol Immunol Infect. 2021;54:299-304.
8.
DorfmanRFBerryGJ. Kikuchi’s histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on differential diagnosis. Semin Diagn Pathol. 1988;5:329-345.
9.
KangHMKimJYChoiEH, et al. Clinical characteristics of severe histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) in children. J Pediatr. 2016;171:208-212.
10.
KwonSYKimTKKimYS, et al. CT findings in Kikuchi disease: analysis of 96 cases. AJNR Am J Neuroradiol. 2004;25:1099-1102.
11.
LinYCHuangHHNongBR, et al. Pediatric Kikuchi-Fujimoto disease: a clinicopathologic study and the therapeutic effects of hydroxychloroquine. J Microbiol Immunol Infect. 2019;52:395-401.
12.
PepeFDismaSTeodoroC, et al. Kikuchi-Fujimoto disease: a clinicopathologic update. Pathologica. 2016;108:120-129.
13.
KimTYHaKSKimY, et al. Characteristics of Kikuchi-Fujimoto disease in children compared with adults. Eur J Pediatr. 2014;173:111-116.
14.
DeaverDHornaPCualingH, et al. Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease. Cancer Control. 2014;21:313-321.
15.
PerryAMChoiSM. Kikuchi-Fujimoto disease: a review. Arch Pathol Lab Med. 2018;142:1341-1346.
16.
PileriSKikuchiMHelbronD, et al. Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol. 1982;395:257-271.
17.
TurnerRRMartinJDorfmanRF. Necrotizing lymphadenitis. a study of 30 cases. Am J Surg Pathol. 1983;7:115-123.
18.
YooIHNaHBaeEY, et al. Recurrent lymphadenopathy in children with Kikuchi-Fujimoto disease. Eur J Pediatr. 2014;173:1193-1199.
19.
TsangWYChanJKNgCSKikuchi's lymphadenitis. A morphologic analysis of 75 cases with special reference to unusual features. Am J Surg Pathol. 1994;18:219-231.
20.
KuoAJPaulsonVAHempelmannJA, et al. Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations. Pract Lab Med. 2020;19:e00153.
21.
BattagliaAFerrandinaGBuzzonettiA, et al. Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire. Immunology. 2003;110:304-312.
22.
ScottGDAtwaterSKGratzingerDA. Normative data for flow cytometry immunophenotyping of benign lymph nodes sampled by surgical biopsy. J Clin Pathol. 2018;71:174-179.
23.
LehmannCLaffertyMGarzino-DemoA, et al. Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients. PLoS One. 2010;5:e11110.
24.
HornyHPWehrmannMGriesserH, et al. Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens. Am J Clin Pathol. 1993;99:142-149.
KishimotoKTateGKitamuraT, et al. Cytologic features and frequency of plasmacytoid dendritic cells in the lymph nodes of patients with histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease). Diagn Cytopathol. 2010;38:521-526.
27.
PilichowskaMEPinkusJLPinkusGS. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): lesional cells exhibit an immature dendritic cell phenotype. Am J Clin Pathol. 2009;131:174-182.
28.
Rollins-RavalMAMarafiotiTSwerdlowSH, et al. The number and growth pattern of plasmacytoid dendritic cells vary in different types of reactive lymph nodes: an immunohistochemical study. Hum Pathol. 2013;44:1003-1010.
29.
SukswaiNJungHRAmrSS, et al. Immunopathology of Kikuchi-Fujimoto disease: a reappraisal using novel immunohistochemistry markers. Histopathology. 2020;77:262-274.
30.
TabataTTakataKMiyata-TakataT, et al. Characteristic distribution pattern of CD30-positive cytotoxic T cells aids diagnosis of Kikuchi-Fujimoto disease. Appl Immunohistochem Mol Morphol. 2018;26:274-282.
31.
NelsonNDMengWRosenfeldAM, et al. Characterization of plasmacytoid dendritic cells, microbial sequences, and identification of a candidate public T-cell clone in Kikuchi-Fujimoto disease. Pediatr Dev Pathol. 2021;24:193-205.
32.
TangFDuQLiuYJ. Plasmacytoid dendritic cells in antiviral immunity and autoimmunity. Sci China Life Sci. 2010;53:172-182.
33.
YoneyamaHMatsunoKZhangY, et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol. 2004;16:915-928.
34.
AinolaMPorolaPTakakuboY, et al. Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjogren’s syndrome. Clin Exp Immunol. 2018;191:301-310.
35.
BonnefoyFPerrucheSCouturierM, et al. Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol. 2011;186:5696-5705.
36.
LovgrenTElorantaMLBaveU, et al. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004;50:1861-1872.
37.
SimpsonJMilesKTrubM, et al. Plasmacytoid dendritic cells respond directly to apoptotic cells by secreting immune regulatory IL-10 or IFN-alpha. Front Immunol. 2016;7:590.
38.
KikuchiASinghKGarsE, et al. Pathology updates and diagnostic approaches to haemophagocytic lymphohistiocytosis. Histopathology. 2022;80:616-626.
39.
LouissaintAJrFerryJASoupirCP, et al. Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features. Mod Pathol. 2012;25:1149-1159.
40.
CalvoKRPriceSBraylanRC, et al. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 2015;125:2753-2758.
41.
HeronMGruttersJCvan MoorselCH, et al. Variation in IL7R predisposes to sarcoid inflammation. Gene Immun. 2009;10:647-653.
42.
BanerjeeSBiehlAGadinaM, et al. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs. 2017;77:521-546.
43.
TanakaTOhmoriMYasunagaS, et al. DNA typing of HLA class II genes (HLA-DR, -DQ and -DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi’s disease). Tissue Antigens. 1999;54:246-253.
44.
IshimuraMYamamotoHMizunoY, et al. A non-invasive diagnosis of histiocytic necrotizing lymphadenitis by means of gene expression profile analysis of peripheral blood mononuclear cells. J Clin Immunol. 2013;33:1018-1026.
45.
AnuntakarunSLarbcharoensubNPayungpornS, et al. Identification of genes associated with Kikuchi-Fujimoto disease using RNA and exome sequencing. Mol Cell Probes. 2021;57:101728.
46.
ChongYKangCS. Causative agents of Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): a meta-analysis. Int J Pediatr Otorhinolaryngol. 2014;78:1890-1897.
47.
GeorgeTIJonesCDZehnderJL, et al. Lack of human herpesvirus 8 and Epstein-Barr virus in Kikuchi’s histiocytic necrotizing lymphadenitis. Hum Pathol. 2003;34:130-135.
48.
RosadoFGTangYWHasserjianRP, et al. Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8. Hum Pathol. 2013;44:255-259.
49.
XuZLiuYLiH, et al. Detection of mycobacterial and viral DNA in Kikuchi-Fujimoto disease: an analysis of 153 Chinese pediatric cases. Sci China Life Sci. 2017;60:775-777.
50.
BoschXGuilabertAMiquelR, et al. Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol. 2004;122:141-152.
ImamuraMUenoHMatsuuraA, et al. An ultrastructural study of subacute necrotizing lymphadenitis. Am J Pathol. 1982;107:292-299.
53.
Quintas-CardamaAFragaMCozziSN, et al. Fatal Kikuchi-Fujimoto disease: the lupus connection. Ann Hematol. 2003;82:186-188.
54.
SantanaALessaBGalraoL, et al. Kikuchi-Fujimoto’s disease associated with systemic lupus erythematosus: case report and review of the literature. Clin Rheumatol. 2005;24:60-63.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
